probiotics prevention pediatric antibiotic-associated diarrhea pubmed ncbi abstract background antibiotics alter microbial balance gastrointestinal tract probiotics prevent antibiotic-associated diarrhea aad restoration gut microflora antibiotics prescribed frequently children aad common population objectives assess efficacy adverse effects probiotics strain dose prevention antibiotic-associated diarrhea children assess adverse events probiotics co-administered antibiotics children search strategy medline embase central cinahl amed web science inception august num searched specialized registers including cochrane ibd/fbd review group ciscom chalmers pedcam research register trial registries inception num letters authors included trials nutra/pharmaceutical companies experts field requesting additional information ongoing unpublished trials conference proceedings dissertation abstracts reference lists included relevant articles hand searched selection criteria randomized parallel controlled placebo active treatment trials comparing co-administered probiotics antibiotics prevention diarrhea secondary antibiotic children num num years data collection analysis methodological quality assessment data extraction conducted independently authors bcj dichotomous data incidence diarrhea adverse events combined pooled relative risks continuous data duration diarrhea daily stool frequency weighted differences num confidence intervals adverse events summarized risk difference pooled results incidence diarrhea priori sensitivity analyses included protocol versus intention treat random versus fixed effects methodological quality criterion subgroup analysis conducted probiotic strain dose definition antibiotic-associated diarrhea antibiotic agent main results ten studies met inclusion criteria trials included treatment lactobacilli spp bifidobacterium spp streptococcus spp saccharomyces boulardii combination studies single strain probiotic agent combined probiotic strains protocol analysis num trials reporting incidence diarrhea show statistically significant results favouring probiotics active/non active controls rr num num ci num num intention treat analysis showed non-significant results rr num num ci num num ten trials monitored adverse events num reported adverse event authors conclusions probiotics show promise prevention pediatric aad protocol analysis yields treatment effect estimates statistically clinically significant analysis high quality studies estimate intention treat analysis statistically significant future studies involve probiotic strains doses promising evidence e g lactobacillus gg lactobacillus sporogenes saccharomyces boulardii num num billion colony forming units/day research date permit determination effect age e g infant versus older children antibiotic duration e g num days versus num days future trials benefit validated primary outcome measure antibiotic-associated diarrhea sensitive change reflects treatment effect clinicians parents children important current data promising premature routinely recommend probiotics prevention pediatric aad 
